BC Cancer researchers are playing a central role in a new international collaboration aimed at developing innovative treatments for osteosarcoma — a highly malignant bone cancer that commonly affects children and adolescents.
Applicants interested in pursuing graduate or postdoctoral training in The Department of Molecular Oncology, please e-mail us directly at careersmolonc@bccrc.ca. Please include the following documents when applying:
The expected salary range for this position is $60,000-$80,000 per annum.
At UBC, we believe that attracting and sustaining a diverse workforce is key to the successful pursuit of excellence in research, innovation, and learning for all faculty, staff and students. Our commitment to employment equity helps achieve inclusion and fairness, brings rich diversity to UBC as a workplace, and creates the necessary conditions for a rewarding career.
This year, approximately 4,060 British Columbians will be diagnosed with breast cancer. While many forms of breast cancer can be treated successfully, triple negative breast cancer (TNBC) remains the most deadly subtype because it is resistant to most forms of treatment.
Scientists had previously noted that the presence of a large protein called MondoA was associated with worse outcomes in several pediatric cancers, but they didn’t understand why.
The new test will be able to better diagnose different types of ovarian cancer, a tool that could one day guide and improve treatment options for patients.
After reviewing over 7,000 cancer tissues, the correlation between hormones and aging to developing breast cancer is now better understood.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.